A novel approach to the questions of allosteric properties or a ‘receptor reserve’ of drug binding sites of intestinal smooth muscle cells  by Kuhnen-Clausen, Dida
Volume 39, number 1 FEBS LETTERS February 1974 
A NOVEL APPROACH TO THE QUESTIONS OF ALLOSTERIC PROPERTIES 
OR A ‘RECEPTOR RESERVE’ OF DRUG BINDING SITES OF INTESTINAL 
SMOOTH MUSCLE CELLS * 
Dida KUHNEN-CLAUSEN 
Institut fiir Aerobiologie der Fraunhofer-Gesellschaft 
D 5949 GrafschaftjSauerland, GFR 
Received 5 November 1973 
1. Introduction 
The theories of drug-receptor interactions are ex- 
tensively discussed on the basic assumtption, that po- 
tent cell-stimulating agents need to occupy only a 
small fraction of the total receptor concentration to 
generate maximal response of the effector cell [l-4] . 
This assumption implies the presence of a ‘receptor 
reserve’ and it founded in attempts to reduce the con- 
centration of particular ligand receptors by means of 
irreversible blocking compounds. Frequently, the 
2-halogenoethylamine Dibenamine has been used, 
according to the concept [5], that Dibenamine alkyl- 
ates directly those smooth muscle cell receptors with 
which the drug itself must combine to produce a re- 
sponse [3,4,6]. Recently, this theory has been con- 
tradicted [7]. The supposition was made, that alkyl- 
sting agents produce nonspecific allosteric interac- 
tions with multiple binding sites of the rat jejunum. 
In studies on the parasympatholytic effects of 
quatemary pyridines on the isolated guinea pig ileum 
[8], a treatment with Dibenamine caused changes of 
the activities of some pyridines. These findings are 
not consistent with the elimination of a fraction of 
cholinergic receptors. They are linked to the assump- 
tion of allosteric effects as a consequence of the treat- 
ment by Dibenamine. 
*Some graphs of this contribution have been exposed on the 
occasion of the Ninth International Congress of Biochemistry, 
Stockholm 1973. 
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The dose response curves to cholinergic ligand, act- 
ing at the level of muscarinic receptors of intestinal 
smooth muscle cells, are S-shaped and their Hill coef- 
ficients differ clearly from unity [9] . This parallels 
to the dose response curves of the nicotinic acetyl- 
choline receptor of the electric organ of Electrupho- 
rus electricus [lo- 121, and to the kinetics of regula- 
tory enzymes [ 13,141. An analogy of the regulatory 
properties of cholinoceptive enzymes and receptors 
has been proposed [9]. 
In this letter, the actions of cholinergics and 
cholinolytics on the muscarinic receptor of the iso- 
lated longitudinal muscles of the guinea pig ileum are 
reported and discussed. Attempts were made to pro- 
tect muscarinic or histaminic receptors against the 
irreversible blockade by Dibenamine with specific and 
nonspecific ligands. The phenomena are discussed in 
regard to the theory of the ‘receptor reserve’. 
2. Materials and methods 
Longitudinal muscle strips, isolated from the 
guinea pig ileum according to Paton and Rang [ 151 
were suspended in an organ bath at 37°C containing 
Tyrode solution of the following composition (mM/ 
litre): NaCl 137; KC1 3.7; CaCl, 1.8; MgCl, 1.05; 
NaH,PO, 0.2; NaHCO, 11.9; glucose 5.5. The bath 
was gassed with carbogen, the pH was 7.4-7.5. Iso- 
tonic contractions were recorded on a kymograph. 
The load of the lever was 150 mg. Cumulative dose 
response curves to the cholinergic or histaminic li- 
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gands were performed as described elsewhere [8]. 
Acetyl-P-methylcholine bromide (MeCh) and 
2-furfuryl-trimethyl-ammonium chloride (HFurMe3) 
were used for muscarinic, histamine-dihydrochloride 
(histamine) for histaminic receptor stimulation. The 
benzylate ester of ethyldimethyl-(2-hydroxymethyl) 
ammonium chloride (lachesine), 1 ,l’trimethylene-bis- 
(4-formylpyridinium bromide) dioxime (TMB4) and 
l ,l’oxydimethylene-bis-(4-formyl-pyridinium chlo- 
ride) dioxime (Toxogonin) served as antagonists. 
N,N-Dibenzyl-2-chlorethylamine hydrochloride 
(Dibenamine) was the irreversible inhibitor for mus- 
carinic and histaminic receptors. All experiments were 
performed in the presence of 10e5 M hexamethonium 
in order to avoid ganglionic stimulation. The concen- 
trations of all compounds are indicated as final con- 
centrations. 
3. Results 
3.1. Analysis of the action of choline@ ligunds on 
the muscorinic receptor 
The response of the muscle strip preparation to 
MeCh were calculated as a fraction of the maximum 
contraction or as the percentage of the latter. The da- 
ta were plotted versus the logarithm of the spasmo- 
gen’s concentrations. From these dose response curves, 
concentration producing different standard responses 
(e.g. 5, 10,25, 50...% maximum response) have been 
determined, By this procedure it was possible to plot 
linear dose response curves with intervals smaller than 
that of the original dose response curves. Thus the 
characteristics of the represented curves can be better 
expressed than that of the original values. The data ob- 
tained by this method had been used for the calcula- 
tion of the Hill coefficients. 
Fig. 1 shows the response of the muscle strips as 
a function of increasing concentrations of MeCh. The 
transformation of the sigmoidal curve by the Hill 
equation yields two straight lines with an intercept 
at a concentration of MeCh, generating approxima- 
tely 20-30% maximum contraction. Two Hill coeff- 
cients ‘nH ’ can be determined at 10 and 50% maxi- 
mum response. 
The same graph shows, that a known muscarinic 
antagonist, Lachesine, shifts the dose response curve 
to MeCh to the right, but does not alter significantly 
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Fig. 1. Cumulative dose response curve to acetyl-/3-methyl- 
choline (MeCh) and the effect of the specific antagonist 
Lachesine on the shape and position of the curve. EA = 
dose dependent contraction of the longitudinal muscle strip 
of the guinea pig ileum as fraction of the maximum effect, 
Em, of MeCh. The inset represents the respective Hill plots, 
with EA as % of Em. The Hill coefficients were calculated at 
the points corresponding to 10 and 50% maximum contrac- 
tion. 
the shape of the curve or the Hill coefficients. The 
double reciprocal plot of the dose response curves 
of fig. 1 yields curves, which can be fitted reasonably 
by a hyperbola. 
The quatemary bispyridines Toxogonin and 
TMB4 are rather weak antagonists, when compared 
with Lachesine [8]. In the presence of these com- 
pounds, the shapes of the dose response curves to 
MeCh are more approached to a hyperbola than to 
the S-form. The Hill coefficients are slightly but sig- 
nificantly decreased. 
In the presence of different single doses of MeCh, 
the dose response curves to Lachesine or Toxogonin 
are converted from a hyperbola into a S-shaped curve, 
when the concentration of MeCh exceeds 1 OW6 M. 
The Hill plots of these curves are reasonably fitted by 
a straight line with a negative slope (nH for Lachesine 
= 2.03, for Toxogonin = 1.76). 
Fig. 2 shows dose response curves to MeCh alone 
and in the presence of one single concentration of 
another muscarinic receptor stimulator. HFurMe3 
shifts to dose response curve to MeCh to the left and 
converts its shape into a hyperbola. The Hill coeffi- 
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Fig. 2. The effect of the muscarinic agonist furthrethonium 
(HFurMes) on the shape and position of the dose respcnse 
curve to acetyl-p-methylcholine (MeCh). The inset shows the 
analysis of the curves by the Hill equation. For further expla- 
nation see text of fig. 1. 
cient of this curve appraches to one. The double re- 
ciprocal plot yields a straight line. 
3.2. Protection of cholinergic and histaminic ligand 
binding sites against the irreversible blockade by 
Dibenamine 
When the muscle strips are exposed to Dibenamine 
for 20 min, and nonbound Dibenamine is removed by 
repeated rinsing, the dose response curves to MeCh or 
histamine are shifted to the right, and the maximum 
responses decrease. Recovery does not occur within 
the experimental period. 
In the protection experiments, the organ bath was 
supplemented with different single concentrations of 
the respective agonist, or of Lachesine or TMB4, 2 
min before Dibenamine was added. After an incuba- 
tion for 20 min, the muscle strips were rinsed at least 
10 times. Fig. 3a and 4a represent the dose response 
curves to the agonists after this treatment. 
The specific ligand for muscarinic binding sites, 
MeCh, has only slight protective properties against 
Dibenamine (fig. 3a). The dose investigated is that 
needed for maximum response. An increase in the con- 
centration of MeCh does not increase the protective ef- 
fect. Lachesine prevents the effect of Dibenamide bet- 
ter than MeCh, but here again an increase in the concen- 
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Fig. 3. The effect of the irreversible receptor inactivator 
Dibenamine (Dib) in the presence and in the absence of 
acetyl-P-methylcholine (MeCh), Lachesine (Lath) or TMB-4: 
a) dose response curves to MeCh after the indicates treatment, 
in the absence of any other compounds (homotropic effects); 
b) the analysis of the dose response curves to MeCh by the 
Hill equation. For experimental details see text. 
tration over the level, indicated in fig. 3a, does not 
result in an enhanced protection. The concentration 
of 10e7 M Lachesine has an anticholinergic activity 
equieffective to low3 M TMB-4. However, this dose 
of TMB-4 gives full protection against Dibenamine. 
Furthermore, the foot of the dose response curve to 
MeCh is shifted to the left. The shape of the curves 
approaches to a hyperbola, so that the Hill coeffi- 
cients of this curve have lower values than those of 
the control curve and of the curve made after the 
treatment with Dibenamine alone (fig. 3b). 
In order to investigate the specificity of Lachesine 
and TMB4 for the protection of muscarinic ligand 
binding sites, both compounds were used in protec- 
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Fig. 4. The effect of the irreversible receptor inactivator 
Dibenamine (Dib) in the presence and in the absence of 
histamine (Hist), Lachesine (Lath) or TMB-4: a) dose re- 
sponse curves to the homotropic effects of histamine; b) the 
analysis of the dose response curves to histamine by the Hill 
equation. “H Calculated according to fig. 1. 
tion experiments against the alkylation of histamlnic 
binding sites by Dibenamine. Since the recognition 
sites for histamine are very sensitive to Dibenamine, 
this agent was applied in a lower concentration than 
in the experiments with MeCh (fig. 4a). Lachesine 
and TMB-4 are weak histaminic antagonists. They 
were investigated in approximately equieffective con- 
centrations. The experimental conditions are the same 
as mentioned above in regard to fig. 3. 
Fig. 4 shows, that the treatment of the muscle 
strips with Dibenamine shifts doese response curves 
of histamine to the right, reduces the maximum re- 
sponses (fig. 4a) and approaches the Hill coefficients 
to one (fig. 4b). The protective effect of histamine, 
in a three-fold concentration of that needed for maxi- 
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Fig. 5. The effect of furthrethonium (HFurMea) on the 
shape and position of the dose response curve to acetyl-p- 
methylcholine (M&h) before and after the incubation of the 
muscle strips with Dibenamine (Dib) in the presence of the 
combined doses of HFurMea and MeCh. Open symbols: dose 
response curves to MeCh alone (homotropic effects). Closed 
symbols: dose response curves to MeCh in the presence of 
HFurMe3 (heterotropic effects). The dotted line represents 
the inhibitory effect of Dibenamine according to fig. 3. Note 
that the protective effect against Dibenamine by the com- 
bined concentrations of the two muscarinic agonists is more 
than additive. 
mum stimulation, is feeble. It is comparable with the 
protective effect of MeCh (fig. 3). Lachesine and 
TMB4 produce protective effects, reversed than on 
cholinergic binding sites. Now Lachesine is more ef- 
fective than TMB4, and the dose response curve to 
histamine is approached to a hyperbola. The corre- 
sponding Hill coefficients (fig. 4b) have values, some- 
what higher than those from the dose response curve 
after the application of Dibenamine alone. 
In protection experiments at the level of the mus- 
carinic receptor, 2 X 10m7 M HFurMe3 or 1.6 X 
10e7 m MeCh (approximately the ED 50) are unef- 
fective against Dibenamine. These concentrations of 
both receptor activators combined, protect the mus- 
carinic binding site against the inactivation by Diben- 
amine to the same degree as the 30-fold concentration 
of MeCh alone (fig. 3a). After this treatment, the 
simulative effect of 2 X 10B7 M HFurMe3 is lost. In 
some cases (4 of 7 experiments) the response to MeCh 
is inhibited instead of being activated, as shown in 
fig. 5. 
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4. Discussion 
The theory of the ‘receptor reserve’ [2-41 is based 
on the assumption, that irreversible inactivation de- 
creases the sensitivity of the effector cell to the ago- 
nist only by reducing the concentration of the recep- 
tors available for the agonist. Therefore, one common 
recognition site for the agonist, the irreversible inac- 
tivator and for competitive antagonists should be in- 
volved in the drug-receptor and drug-drug interac- 
tion. The assumption excludes receptor-receptor in- 
teraction or cooperativity. 
However, from kinetics of regulatory proteins it is 
known, that S-shaped dose response curves and Hill 
coefficients above unity indicate cooperativity of 
ligand interactions [ 10, 13, 141. The dose response 
curves to MeCh or Histamine are S-shaped, too (figs. 
l-5). The Hill coefficients differ clearly from one 
and are often near two. The displacement of the dose 
response curve to MeCh in the presence of HFurMe,, 
the conversion of its shape into a hyperbola and the 
decrease of the Hill coefficient near unity (fig. 2) indi- 
cates, that the effects of these ligands are not only 
additive but cooperative. 
The phenomena observed parallel the effects of 
muscarinic and histaminic receptor activators on the 
effect of allosteric activators on the excitable mem- 
brane of the electroplax [lo] or on the binding of sub- 
strates to regulatory enzymes [13, 141. It is therefore 
concluded, that recognition sites for MeCh or histamine 
have more than one binding area to which ‘allosteric’ 
ligands can bind. 
The action of Dibenamine seems to be related to 
the ‘desensitization phenomenon’ observed with regu- 
latory proteins. The treatment of those proteins with 
thiol group reagents causes the loss of sensitivity 
without little or no loss of activity associated with 
homotropic ligand binding. The loss of sensitivity is 
accompanied by a loss of regulatory properties, so 
that the Hill coefficient approaches to one. Desensi- 
tization alters also the sensitivity to heterotropic 
ligand. It was presumed, that the desensitizing agents 
interfere with a general mechanism, accounting for 
indirect interaction between topographically distinct 
ligand binding sites [ 10, 13, 141. It has been shown, 
that the homotropic effects of MeCh or histamine 
alter after a treatment with Dibenamine in the way, 
as it was described for the ‘desensitization phenom- 
enon’ (figs. 3 and 4). The alteration of heterotropic ef- 
fects has been noted for the antagonistic activity of 
some quaternary pyridines [8] as well as for the ef- 
fect of a secondary stimulating compound (fig. 5). 
The stereochemical analog of a compound to the 
specific agonist is not required for a more or less com- 
plete protection against the receptor inactivation by 
Dibenamine (TMB4 in fig. 3, Lachesine in fig. 4). 
These effects can be interpreted as effects of allo- 
steric ligands, which bind to areas different from 
binding sites to the agonist, but interdependent on 
them. 
The phenomena reported here are measured by 
means and methods, agreeing with those, on which 
the theory of the ‘receptor reserve’ is based [2-41. 
A different kinetic treatment of the results yet leads 
to an interpretation, which is not consistent with the 
assumption, that Dibenamine acts exclusively on one 
common recognition site for the agonist and its com- 
petitive antagonist. The action of Dibenamine seems 
to be dependent not on the quantity of alkylated re- 
cognition sites for specific ligands, but on the confor- 
mational state of the receptor, induced spontaneously 
or by a protecting ligand. Dibenamine stabilizes the 
receptor by an indirect mechanism in a state, which 
can be irreversibly activated or inactivated with re- 
spect to the specific agonist. There is no evidence, 
that the alkylation of sites of the cell membrane, sen- 
sitive to Dibenamine, can be prevented really by the 
protecting agents. 
This interpretation agrees with the models of 
cholinergic receptors with multiple binding sites 
[7,9, 10, 161. It agrees with the proposition [9], 
that the muscarinic receptors of muscle cells of the 
guinea pig ileum have regulatory properties, analo- 
gous with the acetylcholine receptors of the excitable 
membrane of the electroplax, membrane bound or as 
a purified protein [ 10-12) and with the structure 
bound acetylcholinesterase of bovine erythrocytes 
[17, 181. The proposed analogy of cholinoceptive en- 
zymes and receptors is supported by the morpholog- 
ical similarity of the isolated acetylcholinesterase [191 
and acetylcholine receptor protein from the excitable 
membrane of the electroplax [20] . The interpretation 
of the action of Dibenamine is contradictory to the 
theory of a ‘receptor reserve’ for muscarinic and hist- 
aminic binding sites of intestinal smooth muscle cells. 
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